AzTrials
AzTrials

ObesityNCT02300857

Effects of Macronutrient Diet on Brain Activity

A study testing Low carbohydrate diet, Moderate carbohydrate diet and High carbohydrate diet in people with Obesity, run by Brigham and Women's Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will evaluate the effect of macronutrient diets on brain activity in homeostatic and mesolimbic reward regions. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
Low carbohydrate diet, Moderate carbohydrate diet and High carbohydrate diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
No sites listed yet
Study dates
Nov 2014to 30 Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged 18 to 55 years
  • BMI ≥ 23 kg/m2
  • BMI < 45 kg/m2 and weight ≤ 300 lbs (136 kg)
  • Medical clearance from a primary care provider
  • Student or employee at Framingham State University throughout enrollment in the study
  • Community-based participants from the greater Framingham and Assabet Valley communities
Show all 27Show fewer
  • Willing and able to eat and drink only the foods and beverages on the study menus
  • Willing to eat in the dining hall
  • Willing to abstain from consuming alcohol during participation
  • Additional Inclusion Criteria:
  • Body circumference of <64 in
  • Willingness to undergo 2, 30-minute MRI scans
  • Exclusion Criteria (as detailed in Framingham State Food Study, NCT02068885):
  • Change in body weight exceeding ±10% during prior year
  • Recent adherence to a special diet
  • Recent adherence to a vigorous physical activity regimen (e.g., participation in a varsity sport)
  • Chronic use of any medication or dietary supplement that could affect study outcomes
  • Current smoking (1 cigarette in the last week)
  • Heavy baseline alcohol consumption or history of binge drinking
  • Physician diagnosis of a major medical/psychiatric illness or eating disorder
  • Abnormal blood glucose, TSH, CBC, BUN, Creatinine
  • ALT greater than 150% of the normal upper limit
  • Plans for a vacation during the study that would preclude adherence to prescribed diet
  • Additional exclusions for female participants: Irregular menstrual cycles; any change in birth control medication during the 3 months prior to enrollment; pregnancy or lactation during the 12 months prior to enrollment
  • Additional Exclusion Criteria:
  • Previous bariatric surgery
  • Other contraindications to MRI scanning (severe claustrophobia/extensive orthopedic hardware/pacemaker, cerebral aneurysm clip)

Who cannot join

None listed.

About this study

Official title: Effects of Macronutrient Diet Composition on Brain Reward Activity

This study will evaluate the effect of macronutrient diets on brain activity in homeostatic and mesolimbic reward regions.

Read the detailed description

A question critical to the field of obesity is "what causes overweight and obese individuals to overeat?" One common explanation holds that weight gain at the population-level is caused by increases in the widespread availability of highly palatable foods. An alternative explanation is that the biological effects of the modern diet produce effects in the central nervous system and periphery that augment homeostatic and hedonic hunger. Reducing glycemic load preferentially maintains total energy expenditure during weight-loss maintenance (Ebbeling et al., 2012), and this group of investigators previously showed that in the late postprandial period, a nutrient-controlled high glycemic load vs. low glycemic load meal increases resting regional cerebral blood flow in the nucleus accumbens (Lennerz et al., 2013), part of the mesoaccumbal reward circuitry implicated in craving and addiction. However, the effects of macronutrient composition on blood flow to and activity in homeostatic and reward-related brain regions cannot be fully ascertained from studies of acute ingestion of a single macronutrient, because these do not generalize to mixed-nutrient meals consumed as part of typical American diets. Further, retrospective designs that rely on participant report of frequency of recent macronutrient ingestion and prospective designs with limited duration of diet prescription cannot address the critical question of the long-term, cumulative effects of dietary composition on brain function. Therefore, the investigators propose an approach to identifying brain responses to randomized, mixed-meal diets of varying macronutrient composition during long-term weight-loss maintenance on these diets, using arterial spin labeling (ASL) for regional cerebral blood flow (rCBF) and blood-oxygen-level-dependent (BOLD)-based functional connectivity.

To explore these outcomes, the investigators will partner with the ongoing Framingham State Food Study (NCT02068885): Following weight loss on a standard diet, 150 overweight or obese adults (aged 18 to 65 years) will be randomized to one of three weight-loss maintenance diets varying in carbohydrate to fat ratios for 20 weeks. Investigators will invite subjects already enrolled in the Framingham State Food Study to participate with a goal of enrolling 75 subjects (aiming to be equally divided per diet group following randomization to assigned test diet in the parent study). Participants will complete 1 morning visit to the MRI imaging center at Brigham and Women's Hospital approximately 14-20 weeks into the weight maintenance test diet phase. During the visit, they will undergo a fasting baseline brain imaging session, consume their assigned diet breakfast meal, and undergo a late postprandial brain imaging session. Participants will additionally provide frequent ratings of their food cravings, mood, and anxiety level throughout the visit. The main outcomes will be resting blood flow to the nucleus accumbens and connected striatal regions in the late postprandial period, with additional secondary and other outcomes including blood flow to the hypothalamus and connectivity between the hypothalamus during the late postprandial period.

Conditions
Obesity
Being tested
Low carbohydrate diet, Moderate carbohydrate diet, High carbohydrate diet
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low carbohydrate dietBehavioural

    Feeding study. Composition (by proportion of calories): 20% carbohydrate, 60% fat, 20% protein

  • Moderate carbohydrate dietBehavioural

    Feeding study. Composition (by proportion of calories): 40% carbohydrate, 40% fat, 20% protein

  • High carbohydrate dietBehavioural

    Feeding study. Composition (by proportion of calories): 60% carbohydrate, 20% fat, 20% protein

Study groups in NCT02300857
Study groupRoleWhat they receive
Low carbohydrate dietActive comparatorNot described
Receives: Behavioral: Low carbohydrate diet
Moderate carbohydrate dietActive comparatorNot described
Receives: Behavioral: Moderate carbohydrate diet
High carbohydrate dietActive comparatorNot described
Receives: Behavioral: High carbohydrate diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood flow to the nucleus accumbens and connected striatal regions

    Regional cerebral blood flow (rCBF) measured using arterial spin labeling (ASL) at rest, in neuroanatomically-defined a priori regions (nucleus accumbens, caudate, putamen).

    Measured: 14-20 weeks after initiation of test diet

Secondary outcomes (2)
  1. Blood flow to the hypothalamus

    Regional cerebral blood flow (rCBF) measured using arterial spin labeling (ASL) at rest, in neuroanatomically-defined a priori regions (hypothalamus).

    Measured: 14-20 weeks after initiation of test diet

  2. Functional connectivity between the hypothalamus and nucleus accumbens

    Blood-oxygen-level-dependent (BOLD) fMRI connectivity between neuroanatomically-defined regions of interest (hypothalamus, nucleus accumbens), measured during rest.

    Measured: 14-20 weeks after initiation of test diet

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2014 (estimated)
  2. Study startNov 2014
  3. Primary completion30 Apr 2017
  4. Study completion30 Apr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02300857
Sponsor's protocol ID
2014P001880
Status last verified
Jun 2019
First submitted
20 Nov 2014
Last updated
6 Jun 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Lennerz BS, Alsop DC, Holsen LM, Stern E, Rojas R, Ebbeling CB, Goldstein JM, Ludwig DS. Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutr. 2013 Sep;98(3):641-7. doi: 10.3945/ajcn.113.064113. Epub 2013 Jun 26.

    PubMed 23803881
  • Holsen LM, Hoge WS, Lennerz BS, Cerit H, Hye T, Moondra P, Goldstein JM, Ebbeling CB, Ludwig DS. Diets Varying in Carbohydrate Content Differentially Alter Brain Activity in Homeostatic and Reward Regions in Adults. J Nutr. 2021 Aug 7;151(8):2465-2476. doi: 10.1093/jn/nxab090.

    PubMed 33852013

Questions about this trial

What is this clinical trial studying?

A study testing Low carbohydrate diet, Moderate carbohydrate diet and High carbohydrate diet in people with Obesity, run by Brigham and Women's Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 27 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood flow to the nucleus accumbens and connected striatal regions (time frame: 14-20 weeks after initiation of test diet). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02300857, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in